Latigo Biotherapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 03/09/2026 | Mar 2026Filed 03/09/2026 | Jun 2025Filed 03/09/2026 | Mar 2025Filed 03/09/2026 |
|---|---|---|---|---|
| −$26 | −$23 | −$26 | −$21 | |
| −$27.59 | — | −$36.52 | — | |
| — | — | 0.7 | — |
Trend